Here’s What Pushed Crispr Therapeutics AG Up 23.6% in December – nwitimes.com
nwitimes.com |
Here's What Pushed Crispr Therapeutics AG Up 23.6% in December
nwitimes.com Shares of Crispr Therapeutics AG (NASDAQ: CRSP), a biotech start-up named after the promising new gene-editing technology it's focused on, bounded 23.6% higher in December, according to data from S&P Global Market Intelligence. A new collaboration deal … CRISPR Therapeutics Announces Proposed Public Offering of … A Comparison of Top Movers: Overstock.com, Inc. (OSTK), CRISPR Therapeutics AG (CRSP) Head-To-Head Contrast: Crispr Therapeutics (CRSP) vs. Incyte (INCY) |
